Tobacco firm Imperial Brands is investing in UK biotech company Oxford Cannabinoid Technologies (OCT). The move comes as campaigning to allow marijuana products for medicinal purposes gathers pace.

British American Tobacco said it wanted to "accelerate" its transformation by reducing the health impact of its products. In March, BAT took a stake in Canadian medical cannabis maker Organigram.